Abstract 105P
Background
Cell-free methylated DNA immunoprecipitation sequencing (cfMeDIP-Seq) is a promising approach to assess non-invasive methylomics. Despite its cost-efficiency and accuracy, the setup and processing of cfMeDIP-Seq are technically challenging. The original protocol developed by Shen et al. in 2019 can now be partially automated, potentially improving reproducibility and yield.
Methods
We designed a pilot study to evaluate the performance of cfMeDIP-Seq under 4 library preparation conditions. We collected 4 K2EDTA and 4 PAXgene ccfDNA tubes (BD Vacutainer™) from the same healthy donor. We processed K2EDTA and PAXgene tubes within 2 and 6 hours of blood draw respectively, as previously described (Dameri et al., 2023). We used 10 ng of cfDNA for library preparation. Each condition underwent 2 parallel preparation procedures: one following the manual protocol described by Shen et al., and the other following a semi-automated version of the original protocol using the IP-Star® Compact instrument (Diagenode). We generated a total of 16 libraries, 4 for each condition, and sequenced them on Illumina NovaSeq 6000 device.
Results
The number of uniquely mapped reads was comparable (p-value = 0.8) between semi-automated and manually processed libraries, with an average of 19.9 MReads per sample. The percentage of duplicates was reduced (p-value = 0.0012) in semi-automated libraries (median = 32.88; IQR = 31.94-34.06) compared to manually prepared ones (median = 41.48; IQR = 35.61-42.53). Semi-automated libraries showed a longer mean insert size (255 bp) compared to manually processed libraries (243 bp) with a p-value < 0.01. Principal component analysis revealed no major differences between K2EDTA and PAXgene samples processed with the semi-automated protocol. We observed no significant differences across the 4 conditions in terms of GC content (47%, sd = 0.49).
Conclusions
In the present pilot study, we demonstrated that semi-automated library preparation outperformed the fully manual protocol, regardless of tube type but provided that K2EDTA were processed shortly after collection. Partial automation of fluidic handling seems extremely relevant to increase yield and quality of cfMeDIP-Seq experiments.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Associazione Italiana per la Ricerca sul Cancro (AIRC) and 5x1000 by Italian Ministry of Health.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
146P - The prognosis value of heat-shock proteins in esophagogastric cancer: A systematic review and meta-analysis
Presenter: Eric Nakamura
Session: Cocktail & Poster Display session
Resources:
Abstract
148P - Identification of potential predictive biomarkers for ovarian cancer chemotherapy response
Presenter: Alsina Nurgalieva
Session: Cocktail & Poster Display session
Resources:
Abstract
149P - Rare RAS mutations are associated with recurrence patterns and recurrence-free survival in colon cancer: First results from Morocco
Presenter: Fatima Agy
Session: Cocktail & Poster Display session
Resources:
Abstract
151P - Development of a predictive model for response to neoadjuvant chemoradiation therapy of rectal cancer using the immunologic profile
Presenter: Eun Shin
Session: Cocktail & Poster Display session
Resources:
Abstract
152P - Biomarkers of neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
Presenter: Cibele Masotti
Session: Cocktail & Poster Display session
Resources:
Abstract
153P - BRAF variants and therapy outcomes in melanoma
Presenter: Eftychia Chatziioannou
Session: Cocktail & Poster Display session
Resources:
Abstract
154P - The impact of proton pump inhibitors in the prognosis of patients with non-metastatic nasopharyngeal carcinoma
Presenter: João Barbosa Martins
Session: Cocktail & Poster Display session
Resources:
Abstract
155P - Use of machine learning for the identification of molecular biomarkers to predict response to neoadjuvant chemotherapy in locally advanced breast cancer patients
Presenter: María Del Río Pisula
Session: Cocktail & Poster Display session
Resources:
Abstract
156P - Molecularly driven therapy recommended by a molecular tumor board: Accessible option or privilege for a minority of patients? A single-center experience from the Czech Republic
Presenter: Michal Eid
Session: Cocktail & Poster Display session
Resources:
Abstract
157P - PCM4EU academy: An educational program for precision oncology
Presenter: Loic Verlingue
Session: Cocktail & Poster Display session
Resources:
Abstract